1. MitraClip procedure as ‘bridge to list’, the ultimate therapeutic option for end‐stage heart failure patients not eligible for heart transplantation due to severe pulmonary hypertension
- Author
-
Stefano Ghio, Fabrizio Gazzoli, Claudia Raineri, Valeria Gritti, Gabriele Crimi, Laura Scelsi, Giulia Magrini, Maurizio Ferrario, Valeria Crescio, Luigi Oltrona Visconti, and Annalisa Turco
- Subjects
Pulmonary and Respiratory Medicine ,lcsh:Diseases of the circulatory (Cardiovascular) system ,medicine.medical_specialty ,medicine.medical_treatment ,MitraClip procedure ,Case Report ,030204 cardiovascular system & hematology ,heart transplantation ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,030212 general & internal medicine ,end-stage heart failure ,lcsh:RC705-779 ,Heart transplantation ,business.industry ,MitraClip ,lcsh:Diseases of the respiratory system ,medicine.disease ,Pulmonary hypertension ,eye diseases ,medicine.anatomical_structure ,lcsh:RC666-701 ,Heart failure ,Vascular resistance ,Cardiology ,mitral regurgitation ,End stage heart failure ,business ,Medical therapy - Abstract
Patients with end-stage heart failure (HF), pulmonary hypertension and elevated pulmonary vascular resistance (PVR) despite medical therapy are not eligible for heart transplantation (HTx). In this ‘proof of concept’ case series, we demonstrate the feasibility and efficacy of the MitraClip procedure as ‘bridge to list’ in end-stage HF patients not eligible for HTx. In fact, in the three patients reported, who were initially excluded from the HTx list because of elevated PVR, the MitraClip procedure was followed by a sustained improvement of PVR, allowing the patients’ risk to be reclassified, and they were then considered eligible for HTx.
- Published
- 2018
- Full Text
- View/download PDF